Intestinal metaplasia
Conditions
Interventions
Gold Standard:Pathologic diagnosis
Index test:Methylation Detection
Sponsors
The First Hospital of Jilin University
Eligibility
Sex/Gender
All
Age
40 Years to 74 Years
Inclusion criteria
Inclusion criteria: 1) Pathologic diagnosis of Intestinal Metaplasia and not combined with high-grade dysplasia/high-grade intraepithelial neoplasia; 2) Age >= 40 years and <75 years; 3) Signed informed consent and willingness to follow the blood collection and assessment of this study.
Exclusion criteria
Exclusion criteria: 1) Pregnant and lactating women; 2) Those with previous or current cancer history(including Carcinoma in situ); 3) History of severe acute infectious disease (e.g., severe and acute new coronavirus infection, sepsis, etc.) within 14 days prior to screening. 4) Use of the following medications within 14 days prior to screening: intravenous/oral glucocorticosteroids; intravenous/oral azacitidine, decitabine, procainamide, hydrazine, arsenic trioxide, or other drugs; 5) Having received an organ transplant, bone marrow transplant, stem cell transplant, or blood transfusion within 30 days prior to screening. 6) Other circumstances that the investigator consider inappropriate to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Specificity;Accuracy;Sensitivity; | — |
Countries
China
Contacts
Public ContactHong Xu
The First Hospital of Jilin University
Outcome results
None listed